High-throughput screening program to target ovarian cancer leader cells

被引：0

|

作者：

Karimnia, Nazanin ^{[1
]}

Bilandzic, Maree ^{[2
]}

Plebanski, Magdalena ^{[3
]}

Stephens, Andrew N. ^{[2
]}

机构：

[1] Monash Univ, Melbourne, Vic, Australia

[2] Hudson Inst Med Res, Melbourne, Vic, Australia

[3] RMIT Univ, Melbourne, Vic, Australia

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-6338

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6338

引用

收藏

页数：2

相关论文

共 50 条

[21] High-throughput screening
Persidis, A
NATURE BIOTECHNOLOGY, 1998, 16 (05) : 488 - 489
[22] High-throughput screening
Wallace, RW
DRUG DISCOVERY TODAY, 1998, 3 (02) : 92 - 93
[23] High-throughput screening
不详
GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2007, 27 (20): : 1 - +
[24] High-throughput screening
Rogers, MV
DRUG DISCOVERY TODAY, 1997, 2 (06) : 251 - 251
[25] High-throughput screening
Rogers, MV
DRUG DISCOVERY TODAY, 1997, 2 (05) : 209 - 209
[26] High-throughput screening
Nature Biotechnology, 2005, 23 (6) : 755 - 755
[27] High-throughput screening
Nature Biotechnology, 2001, 19 (7) : 689 - 689
[28] High-throughput screening
Nature, 2001, 413 (6855) : 549 - 550
[29] High-Throughput Screening
Wildey, Mary Jo
Haunso, Anders
Tudor, Matthew
Webb, Maria
Connick, Jonathan H.
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 50: PLATFORM TECHNOLOGIES IN DRUG DISCOVERY AND VALIDATION, 2017, 50 : 149 - 195
[30] High-throughput screening
Rogers, MV
DRUG DISCOVERY TODAY, 1997, 2 (07) : 306 - 306

← 1 2 3 4 5 →